生理学的研究のための全固体型イオン選択性電極（ASSISE）に基づき、多検体バイオチップ（MAB）

Executive Industry Relevance

The multi-analyte biochip (MAB) enables real-time, multiplexed ion sensing in complex biological media, addressing a critical need for stable, long-term monitoring in discovery-stage physiological research. Its all-solid-state design using PEDOT transducer layers supports extended storage stability, reducing assay drift and improving data reliability for target validation workflows. This capability enhances predictive confidence in early discovery by providing quantitative, reproducible ion activity readouts that inform mechanistic de-risking of ion transport pathways.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of ion flux dynamics in live biological systems to validate therapeutic targets involved in calcium, proton, or carbonate signaling.
• Operational Value: Supports hypothesis testing through real-time, non-invasive monitoring of ion activities without perturbing cellular physiology.
• Predictive Value: Provides near-Nernstian response after extended storage, increasing confidence in longitudinal data for pathway de-risking.

Screening & Assay Development

• Assay Readiness: Generates stable, quantifiable potentiometric outputs for H+, Ca2+, and CO32- ions, enabling standardized screening conditions.
• Reproducibility: Demonstrates consistent calibration curves across biological media, supporting assay transferability between discovery and preclinical teams.
• Multiplexing Capacity: Integrates nine working electrodes on a single chip, allowing parallel ion profiling to accelerate lead identification efforts.

Translational & Preclinical Research

• Disease Relevance: Enables physiological measurements in model systems like Chlorella vulgaris, supporting translational biomarker alignment for ion-related pathways.
• Preclinical Continuity: Maintains functional stability in algal medium for up to one month, facilitating longitudinal studies across discovery stages.
• Risk-Adjusted Advancement: Delivers reliable ion activity trends that inform go/no-go decisions based on electrophysiological readouts.

Pipeline & Workflow Integration

The MAB fits within the discovery continuum from early target validation through preclinical profiling by delivering quantitative ion activity data that supports hypothesis-driven screening and mechanistic follow-up.

• Discovery Biology: Supports functional validation of ion channels and transporters via real-time monitoring of H+, Ca2+, and CO32- fluxes in live cells.
• Screening: Enables reproducible, multiplexed ion sensing in microfluidic formats, improving throughput and data consistency in compound effect profiling.
• Analytics: Delivers potentiometric readouts with near-Nernstian slopes, allowing accurate comparison of ion activities across experimental conditions.
• Translational Research: Connects discovery-phase ion measurements to preclinical validation through stable performance in biological media.
• Enterprise Reuse: Designed for batch fabrication and conditioning, positioning the MAB as a reusable platform across multiple projects and therapeutic areas.

Operational & Enterprise Impact

• Scientific Value: Reduces mechanistic ambiguity in ion signaling pathways through direct, label-free measurement of physiological ion activities.
• Operational Value: Eliminates need for frequent recalibration due to extended storage stability, improving workflow efficiency.
• Strategic Value: Increases confidence in early-stage data, supporting better go/no-go decisions and reducing late-stage biological failure risk.
• Portfolio Impact: Enables risk-adjusted prioritization of targets based on reliable ion flux profiles in disease-relevant systems.

Implementation Considerations

• Requires expertise in electrochemistry and microfluidic interface design for proper electrode functionalization and signal acquisition.
• Depends on potentiostat or equivalent instrumentation capable of open-circuit potential measurement and real-time recording.
• Necessitates standardization of conditioning protocols (e.g., overnight incubation in bicarbonate/chloride media) across teams to ensure sensor reproducibility.
• Adaptation to mammalian cell systems may require optimization of ionic strength and biocompatibility of microfluidic materials.
• Practical limitation: Ion-selective membrane stability can be affected by prolonged exposure to surfactants or proteins, necessitating careful sample preparation.

Biopharma FAQs